Article
The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy.
PloS one - 1 Jan 2013
Zhou Fei, Gao Guanghui, Ren Shengxiang, Li Xuefei, He Yayi, Zhou Caicun
Abstract excerpt
BACKGROUND AND OBJECTIVE: Overexpression of COX-2 is proved to contribute to tumor promotion and carcinogenesis through stimulating cell proliferation, inhibiting apoptosis and enhancing the invasiveness of cancer cells. Apoptosis-related molecules are potential predictive markers for survival and toxicity in platinum treatment. This study aimed at investigating the association between COX-2 polymorphisms and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
